Raj K. Puri Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Raj K. Puri is Chief Regulatory Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 215,859 shares of IOVA, which is worth approximately $533,171. The most recent transaction as insider was on Dec 01, 2025, when has been sold 2,467 shares (Common Stock) at a price of $2.23 per share, resulting in proceeds of $5,501. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 216K

1.41% 3M change

n/a 12M change

Total Value Held $533,171

Raj K. Puri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Payment of exercise price or tax liability	$5,501 $2.23 p/Share	2,467 Reduced 1.13%	215,859 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	5,469 Added 2.44%	218,326 Common Stock
Sep 02 2025	SELL Payment of exercise price or tax liability	$5,402 $2.19 p/Share	2,467 Reduced 1.15%	212,857 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	-	5,470 Added 2.48%	215,324 Common Stock
Jun 02 2025	SELL Payment of exercise price or tax liability	$4,341 $1.76 p/Share	2,467 Reduced 1.16%	209,854 Common Stock
Jun 02 2025	BUY Exercise of conversion of derivative security	-	5,469 Added 2.51%	212,321 Common Stock
May 23 2025	BUY Open market or private purchase	$9,744 $1.74 p/Share	5,600 Added 2.64%	206,852 Common Stock

Mar 14 2025	SELL Payment of exercise price or tax liability	$9,007 $3.59 p/Share	2,509 Reduced 1.23%	201,252 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	-	8,334 Added 3.93%	203,761 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$80,735 $4.04 p/Share	19,984 Reduced 9.28%	195,427 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	59,999 Added 21.79%	215,411 Common Stock
Dec 16 2024	SELL Payment of exercise price or tax liability	$29,470 $7.84 p/Share	3,759 Reduced 2.36%	155,412 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	-	8,334 Added 4.98%	159,171 Common Stock

RKP

Raj K. Puri

Chief Regulatory Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account